Last reviewed · How we verify

Ultrasound guided regional anesthesia

Medical University of Graz · Phase 3 active Small molecule

Ultrasound guided regional anesthesia is a Small molecule drug developed by Medical University of Graz. It is currently in Phase 3 development for Pain management during surgical procedures. Also known as: dexmedetomidine, Ropivacaine.

Ultrasound guided regional anesthesia involves the use of ultrasound technology to guide the injection of anesthetic agents into specific areas of the body, providing targeted pain relief.

Ultrasound guided regional anesthesia involves the use of ultrasound technology to guide the injection of anesthetic agents into specific areas of the body, providing targeted pain relief. Used for Pain management during surgical procedures.

At a glance

Generic nameUltrasound guided regional anesthesia
Also known asdexmedetomidine, Ropivacaine
SponsorMedical University of Graz
ModalitySmall molecule
Therapeutic areaAnesthesiology
PhasePhase 3

Mechanism of action

This approach allows for more precise delivery of anesthetics, reducing the risk of complications and improving patient outcomes. The use of ultrasound guidance enables the anesthesiologist to visualize the needle placement in real-time, ensuring accurate injection of the anesthetic agent into the desired location.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Ultrasound guided regional anesthesia

What is Ultrasound guided regional anesthesia?

Ultrasound guided regional anesthesia is a Small molecule drug developed by Medical University of Graz, indicated for Pain management during surgical procedures.

How does Ultrasound guided regional anesthesia work?

Ultrasound guided regional anesthesia involves the use of ultrasound technology to guide the injection of anesthetic agents into specific areas of the body, providing targeted pain relief.

What is Ultrasound guided regional anesthesia used for?

Ultrasound guided regional anesthesia is indicated for Pain management during surgical procedures.

Who makes Ultrasound guided regional anesthesia?

Ultrasound guided regional anesthesia is developed by Medical University of Graz (see full Medical University of Graz pipeline at /company/medical-university-of-graz).

Is Ultrasound guided regional anesthesia also known as anything else?

Ultrasound guided regional anesthesia is also known as dexmedetomidine, Ropivacaine.

What development phase is Ultrasound guided regional anesthesia in?

Ultrasound guided regional anesthesia is in Phase 3.

What are the side effects of Ultrasound guided regional anesthesia?

Common side effects of Ultrasound guided regional anesthesia include Nerve damage.

Related